Truly can't imagining having drama with Reese Witherspoon, but apparently she and an unnamed A-list actress are no longer on speaking terms. Why, you ask? Because Reese accidentally roasted her ...

SEOUL – South Korean actress Lee Joo-sil, who most recently appeared in the second season of global hit Squid Game (2021 to present), has died at the age of 80 on Feb 2, her agency 1230Culture said.

I’m Still Here (2024) FERNANDA TORRES as Eunice Credit: Adrian Teijido/Sony Pictures Classics Sony Pictures Classics Best Actress commentary (Updated Feb. 6, 2025): The acclaim for Fernanda ...

Taiwanese actress Barbie Hsu has died at the age of 48, after contracting pneumonia that developed following the flu. The star, known by her fans as Da S (Big S), rose to fame in the TV drama ...

Sir Keir Starmer used a Shakespearean actress to help him get over stage fright as she admits he would 'shut down' when he was out of his comfort zone. The premier first called in ...

Sir Keir Starmer relied for five years on an actress and communications skills coach to improve his public speaking and interview performances, a new book has revealed. The prime minister relied ...

All in all, Ingrezza pulled in $2.3 billion in 2024, making for an “all-time record growth year” for the drug, Benevich noted. Teva's Austedo, meanwhile, collected $1.6 billion in sales last year.

Entertainment Weekly's Oscars expert, 'RuPaul's Drag Race' beat reporter, host of 'Quick Drag' Twitter Spaces, and cohost of 'EW's BINGE' podcast. Almost all of the drag content on this site is my ...

He emphasized the strong performance of INGREZZA, which is poised for double-digit year-over-year growth despite moderated expectations compared to 2024, the company’s highest growth year to date.

INGREZZA Sales Guidance for 2025: $2.5 billion to $2.6 billion, reflecting $250 million growth at the midpoint. CRENESSITY Q4 2024 Sales: $2 million in net sales from initial bottle orders.

Neurocrine Biosciences Q4 EPS of $1.69 beat estimates, while revenue missed consensus. Ingrezza sales rose 23% to $615 million. 2025 Ingrezza sales guidance fell short of Street estimate.